Pivekimab, referred to as IBAT®, is a innovative synthesized cloned antibody engineered with directly bind to and inhibit interleukin-6, the critical inflammatory mediator implicated to multiple pathogenic responses https://socialrus.com/story24805036/pivekimab-the-deep-copyrightination-of-a-synthetic-monoclonal-antibody